Cognitive Bias Modification (CBM) and Obsessive Compulsive Beliefs

Not Applicable

• Conditions: Obsessive compulsive disorder; Mental Health - Other mental health disorders

• Registration Number: ACTRN12613001130752
• Lead Sponsor: St Vincent's Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2013-10-10
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Stopped early
• Sex: All
• Target Recruitment: 70

Inclusion Criteria

Meet Lifetime diagnostic criteria for Obsessive Compulsive Disorder (DSM-IV and DSM 5 criteria will be assessed). Internet access;
Australian resident;
Fluent in written and spoken English.

Exclusion Criteria

Presence of severe depression and/or suicidal ideation;
lifetime psychotic symptoms or bipolar disorder; current substance abuse; current or planned psychological treatment during study
duration; change in medication during last 1 month or intended change during study duration, use of Benzodiazepines; not fluent in written and spoken English.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Change in score on the OC Bias Measure[Administered at Baseline (T1), Post-CBM intervention (T2, 1 week after baseline), and at 1 month follow-up (T3).];Change in score on the Ambiguous Scenarios Test for OCD (AST-OCD)[Administered at Baseline (T1), Post-CBM intervention (T2, 1 week after baseline), and at 1 month follow-up (T3).];Change in score on the OBQ-TRIP[Administered at Baseline (T1), Post-CBM intervention (T2, 1 week after baseline), and at 1 month follow-up (T3).]

Secondary Outcome Measures

Name	Time	Method
Change in score on the Dimensional Obsessive-Compulsive Scale (DOCS)[Administered at Baseline (T1), Post-CBM intervention (T2, 1 week after baseline), and at 1 month follow-up (T3).];Change in score on the Patient Health Questionnaire (PHQ-9)[Administered at Baseline (T1), Post-CBM intervention (T2, 1 week after baseline), and at 1 month follow-up (T3).];Change in score on the Kessler-10 (K10) Psychological Distress Scale [Administered at Baseline (T1), Post-CBM intervention (T2, 1 week after baseline), and at 1 month follow-up (T3).];Change in score on the Word Sentence Association Test for OCD (WSAO)[Administered at Baseline (T1), Post-CBM intervention (T2, 1 week after baseline), and at 1 month follow-up (T3).];Treatment Expectancy and Outcomes Questionnaire[Administered at Baseline (T1), Post-CBM intervention (T2, 1 week after baseline), and at 1 month follow-up (T3).]